INTERNATIONAL PATENT: SANGAMO THERAPEUTICS, INC. FILES APPLICATION FOR "ENGINEERED MODULAR RECOMBINASE COMPOSITIONS, METHODS AND SYSTEMS FOR SITE-SPECIFIC DNA RECOMBINATION"

GENEVA, Oct. 15 -- SANGAMO THERAPEUTICS, INC. (501 Canal Blvd.Suite A100Richmond, California 94804) filed a patent application (PCT/US2025/023078) for "ENGINEERED MODULAR RECOMBINASE COMPOSITIONS, METHODS, AND SYSTEMS FOR SITE-SPECIFIC DNA RECOMBINATION" on Apr 03, 2025. With publication no. WO/2025/212976, the details related to the patent application was published on Oct 09, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): MILLER, Jeffrey C. (c/o Sangamo Therapeutics, Inc.501 Canal Blvd.Suite A100Richmond, California 94804), FAUSER, Friedrich A. (c/o Sangamo Therapeutics, Inc.501 Canal Blvd...